11 results
424B3
IKT
Inhibikase Therapeutics Inc
4 Apr 23
Prospectus supplement
4:57pm
to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against fraud and abuse, add transparency requirements … is the fourth rule in a series that implement the No Surprises Act and transparency requirements of the Consolidated Appropriations Act (CAA), 2021
POS AM
IKT
Inhibikase Therapeutics Inc
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against fraud and abuse, add transparency … . The rule is the fourth rule in a series that implement the No Surprises Act and transparency requirements of the Consolidated Appropriations Act (CAA
424B4
v2dd7x 0wpb
17 Jun 21
Prospectus supplement with pricing info
4:31pm
DRS
c4rj 2432v
2 Jun 21
Draft registration statement
12:00am
10-K
r79r0e
31 Mar 21
Annual report
2:14pm
DRSLTR
witutp1
15 Oct 18
Correspondence regarding draft registration statement
12:00am
UPLOAD
ue566ujz7qtej
10 Oct 18
Letter from SEC
12:00am
- Prev
- 1
- Next